Navigation Links
The Pancreatic Cancer Action Network Is Saddened by the Death of Actor Patrick Swayze
Date:9/14/2009

EL SEGUNDO, Calif., Sept. 14 /PRNewswire/ -- The Pancreatic Cancer Action Network (www.pancan.org), the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure is mourning the loss of legendary actor Patrick Swayze. His diagnosis shocked fans around the world in early 2008 and his subsequent battle put a spotlight on pancreatic cancer, the fourth leading cause of cancer death in the United States. Swayze is the latest celebrity to succumb to this deadly disease, others before him include: Chuck Daly, Randy Pausch, Luciano Pavarotti, Michael Landon, Donna Reed, Juliet Prowse, Joan Crawford and Jack Benny among others.

"On behalf of the Pancreatic Cancer Action Network, I would like to offer my condolences to his wife, Lisa and the entire Swayze family," said Julie Fleshman, President and CEO. "For nearly two years he was beating the odds stacked against him and his brave, public battle was a beacon of hope for the pancreatic cancer community. The Pancreatic Cancer Action Network will continue to advance research, support patients and create hope in his memory."

Pancreatic cancer is the most lethal cancer in the United States with a five-year survival rate of only 5 percent. This year, over 42,000 people will be diagnosed with the disease and over 35,000 will die. Despite the statistics, pancreatic cancer is the most under-funded among leading cancer killers with less than 2 percent of the National Cancer Institute's annual research budget - a figure far too low given the severity of the disease.

In January 2009, the pancreatic cancer community took an important step forward of increased federal research funding for pancreatic cancer by developing the first-ever substantive pancreatic cancer legislation introduced in the U.S. Congress. The Pancreatic Cancer Research and Education Act (H.R. 745), which was introduced by U.S. Representatives Anna Eshoo (D-CA) and Ginny Brown-Waite (R-FL), proposes comprehensive research initiatives and programs that would facilitate finding a cure for pancreatic cancer. Once enacted and fully funded, this legislation will create a more targeted approach to fighting pancreatic cancer and provide scientists with the resources necessary to make significant advances.

To learn more about the Pancreatic Cancer Action Network, visit www.pancan.org.

About the Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research - and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic cancer.

The Pancreatic Cancer Action Network fills the void of information and options by giving patients and caregivers reliable, personalized information they need to make informed decisions. We create a sense of hope and community so no one has to face pancreatic cancer alone. The organization helps support individuals and communities all across the country work together to raise awareness and funds to find a cure for pancreatic cancer.

Available Topic Expert(s): For information on the listed expert(s),

click appropriate link.

Julie Fleshman

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=75525


'/>"/>
SOURCE Pancreatic Cancer Action Network
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MicroRNAs circulating in blood show promise as biomarkers to detect pancreatic cancer
2. Pancreatic Cancer Deaths Higher for Blacks
3. Blood Test May Spot Pancreatic Cancer Early
4. Blood Flow Mismatch Seen in Pancreatic Cancers
5. Abnormal Protein May Signal Pancreatic Cancer
6. Blood Type May Boost Pancreatic Cancer Risk
7. Metformin May Lower Diabetics Odds for Pancreatic Cancer
8. Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others
9. Smoking increases potential for metastatic pancreatic cancer
10. New drug candidate prolongs the lives of pancreatic cancer patients
11. Dietary fat linked to pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... ... 27, 2017 , ... From May 21-23, hearing healthcare professionals gained a competitive ... at the Marriott Syracuse Downtown Hotel in Syracuse, New York. , As EarQ’s ... hearing healthcare providers to help them stay ahead in the industry. At the event, ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from biotech, ... 30th and 31st at The Four Seasons Hotel Boston. , The Boston ... sciences, offering exclusive access to key decision makers who influence deal making and ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of ... the healthiest seniors are located in the Midwest. With the average cost of healthcare ... people are concerned with both the quality and affordability of where they live. An ...
(Date:5/26/2017)... ... ... After raising nearly $30,000 on Kickstarter , about three-times its original ... discounted crowdfunding price on Indiegogo . , “Along with creating an anti-stress gadget ... a fidget toy to the market that was made of superior quality and wouldn’t ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled ... a new, informational blog post on insurance options. If a Bay Area patient has ... help save time and money. Visiting an in-network provider for a second opinion can ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... N.Y. , May 22, 2017  Lilac ... treatment Gene-Eden-VIR/Novirin, announces the launch of a ... English, the results of a clinical study that ... year treatment with Gene-Eden-VIR/Novirin in individuals suffering from ... to note that there are no other treatments ...
(Date:5/15/2017)... , May 15, 2017  Amy Baxter MD, ... industry leader in noninvasive pain relief, was awarded a ... magazine. Baxter was recognized at the MM&M Top ... New York City on May 10, 2017. ... the biopharma industry go "beyond the pill."  ...
(Date:5/10/2017)... May 10, 2017 Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended April 1, 2017 ... $1.84 increased 666.7% compared to the prior year period ... in a significant gain, while non-GAAP diluted EPS of ... or 3.8% in constant currency terms.  Excluding the effects ...
Breaking Medicine Technology: